The pivotal role that the pharmaceutical and healthcare industry plays in Ireland’s economy was the focus of a round-table discussion held today by Guaranteed Irish, the not-for-profit business membership organisation championing 500+ homegrown and international businesses in Ireland.
The session, which was part of the Guaranteed Irish annual ‘Pharmaceutical and Healthcare Month’, was attended by members of the pharmaceutical industry, IDA Ireland and other key industry stakeholders.
The outcomes of the event will be developed into a submission paper for Government by Guaranteed Irish and will outline the support required to ensure the pharmaceutical sector remains in robust health in Ireland.
Pictured at the event were:
- Brid O Connell, CEO of Guaranteed Irish;
- Ger Brennan (Chair), Managing Director, MSD Ireland (Human Health), and member of the Board of Directors at Guaranteed Irish;
- Martin Shanahan, CEO, IDA Ireland;
- Todd Manning, Managing Director, AbbVie, and Deputy Vice President, Irish Pharmaceutical and Healthcare Association (IPHA);
- Matt Moran, Director, BioPharmaChem Ireland (IBEC).
Leading pharmaceutical and healthcare members of Guaranteed Irish include MSD, AbbVie, Hollister Inc., Ipsen, Tosara Pharma Ltd, PPL Biomechanics, KCI Medical Ireland and Nutricia Ireland.
Brid O’Connell, CEO, Guaranteed Irish, says she wants the organisation to work in conjunction with Government to do more to establish Ireland as a ‘practice-leader’ in this field. “Patients are at the very heart of this industry. It is great to know that the Irish pharmaceutical sector is thriving, with the world’s top ten pharmaceuticals based here. We are the 7th largest exporter of medicinal and pharmaceutical products in the world and the sector continues to go from strength to strength – providing high tech, exciting career opportunities and contributing significantly to local communities across Ireland. As a result, we are delighted to be working with our members in this field to highlight the opportunities for the sector in Ireland.”
Speaking at the event, Ger Brennan, Managing Director, MSD Ireland (Human Health), said: “I welcome events such as this morning’s discussion as it is absolutely crucial that the pharmaceutical sector is recognised and indeed celebrated for playing such a pivotal role in Ireland. We are providing high tech, sustainable jobs, contributing significantly to our communities and are working collaboratively with a whole host of stakeholders to ensure this sector continues to go from strength to strength. I think some of the challenges outlined here today such as ensuring patients get timely access to innovative medicines, the need to ensure access to high quality talent and the need to invest in infrastructure such as housing and transport are significant and will require a partnership approach from Government, from key agencies and from industry if we are to tackle them in a meaningful way. I look forward to continuing to work with Guaranteed Irish to highlight how the pharmaceutical sector reflects the values that Guaranteed Irish stands for and continuing to identify ways in which our sector can continue to play a pivotal role in the communities we operate in, the STEM sector generally and the Irish economy.”
Martin Shanahan, CEO, IDA Ireland, said: “Ireland’s Life Sciences sector has grown from very humble beginnings in the 1950s to become a global hub which is home to 10 of the top 10 pharmaceutical companies in the world. The Biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities in Ireland, most of which has come in the last 10 years. This represents one of the biggest waves of investment in new BioTech facilities anywhere in the world. This level of investment is a strong endorsement of Ireland’s offering and in order to remain a compelling location for future investment we must remain keenly focused on Ireland’s competitiveness.”